Assessing the safety of subcutaneous immunotherapy dose adjustments

Annals of Allergy, Asthma and Immunology

Volumn 105, Issue 5, 2010, Pages 369-375

  Webber, Christopher M ^a   Calabria, Christopher W ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASTHMA; CHILD; CLINICAL ASSESSMENT; DILUTION; DRUG DOSE REGIMEN; DRUG SAFETY; FEMALE; HUMAN; IMMUNOTHERAPY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ALLERGENS; ASTHMA; DESENSITIZATION, IMMUNOLOGIC; DRUG DOSAGE CALCULATIONS; DRUG MONITORING; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MEDICATION ADHERENCE; MIDDLE AGED;

EID: 78049472035     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.09.003     Document Type: Article

References (14)

1. Allergen immunotherapy: a practice parameter second update J Allergy Clin Immunol. 120 2007 S25 S85
2. L. Cox, D. Larenas-Linnemann, R.F. Lockey, and G. Passalacqua Speaking the same language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System J Allergy Clin Immunol. 125 2010 569 574 574.e1574.e7
3. I. Finegold Immunotherapy historical perspective Ann Allergy Asthma Immunol. 87 2001 3 4
4. M.S. Lin, E. Tanner, J. Lynn, and G.A. Friday Jr Nonfatal systemic allergic reactions induced by skin testing and immunotherapy Ann Allergy 71 1993 557 562
5. V.F. Ragusa Non-fatal systemic reactions to subcutaneous immunotherapy: a 20-year experience comparison of two 10-year periods Eur Ann Allergy Clin Immunol. 36 2004 52 55
6. L. Cox Allergen immunotherapy and asthma: efficacy, safety, and other considerations Allergy Asthma Proc. 29 2008 580 589
7. C. Moreno Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases Clin Exp Allergy 34 2004 527 531
8. M.A. Rank, C.L. Oslie, J.L. Krogman, M.A. Park, and J.T. Li Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors Allergy Asthma Proc. 29 2008 400 405
9. M. Schiappoli, E. Ridolo, and G. Senna A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy Clin Exp Allergy 39 2009 1569 1574
10. M.S. Tankersley Local reactions during allergen immunotherapy do not require dose adjustment J Allergy Clin Immunol. 106 2000 840 843
11. D.G. Tinkelman Immunotherapy: a one-year prospective study to evaluate risk factors of systemic reactions J Allergy Clin Immunol. 95 1995 8 14
12. L. Winther, J. Arnved, H.J. Malling, H. Nolte, and H. Mosbech Side-effects of allergen-specific immunotherapy: a prospective multi-centre study Clin Exp Allergy 36 2006 254 260
13. A. Bittner, and P.A. Greenberger Incidence of resensitization after tolerating penicillin treatment in penicillin-allergic patients Allergy Asthma Proc. 25 2004 161 164
14. J.R. Montgomery The need for standardizing the aeroallergen immunotherapy missed-dose adjustment protocol [letter] Allergy Asthma Proc. 29 2008 425 426